Patent · US Active

Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins

US11633348B2 · kind B2 · utility

0Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2022
Grant dateApr 25, 2023
Priority date—
Expiry dateMar 18, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/007
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for the cosmetic caring of the skin and/or mucosa, comprising applying a postbiotic composition comprising at least one postbiotic and at least one bacteriocin and/or endolysin, wherein the postbiotic is preferably a bacterial lysate preferably obtained from bacteria heterologously expressing the at least one bacteriocin and/or endolysin and wherein the postbiotic and the at least one bacteriocin and/or endolysin have a synergistic effect in the cosmetic caring method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.